Raymond James & Associates’s SPDR S&P International Health Care Sector IRY Stock Holding History

Raymond James & Associates’s Portfolio IRY Stock Details IRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-5,159	Closed	-$259K	–	3580
2017 Q2	$259K	Buy	5,159 +215	+4%	+$10.6K	﹤0.01%	2823
2017 Q1	$232K	Buy	+4,944	New	+$225K	﹤0.01%	2840
2015 Q3	–	Sell	-18,035	Closed	-$923K	–	2477
2015 Q2	$923K	Buy	+18,035	New	+$956K	﹤0.01%	1781

Other funds holding IRY

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James & Associates's IRY Position: Q3 2017 in Review

Raymond James & Associates sold out of SPDR S&P International Health Care Sector (IRY) in Q3 2017, closing a stake of 5,159 shares — an estimated $259K sold.

Raymond James & Associates first reported a position in IRY in Q2 2015 and held it in 3 quarters. The position peaked at $923K in Q2 2015. 1 fund tracked by Wall St. Rank holds IRY as of Q3 2017.

Raymond James & Associates reported no remaining SPDR S&P International Health Care Sector position as of Q3 2017 after selling out during the quarter.
Raymond James & Associates sold 5,159 SPDR S&P International Health Care Sector shares in Q3 2017, an estimated $259K.
Raymond James & Associates first reported a position in SPDR S&P International Health Care Sector in Q2 2015 and held it in 3 quarters.
Raymond James & Associates's SPDR S&P International Health Care Sector position peaked at $923K in Q2 2015.
1 fund tracked by Wall St. Rank held SPDR S&P International Health Care Sector as of Q3 2017.

Based on Raymond James & Associates's 13F filing for Q3 2017, filed 13 Nov 2017.